Showing results (1-10 of 464) with videos related to
Sort By:
Pageof 47
Proteomics. Clinical Applications|February 1, 2011
CE-MS in biomarker discovery, validation, and clinical applicationHarald Mischak, Joost P SchanstraPediatric Nephrology (Berlin, Germany)|March 18, 2014
Proteomic urinary biomarker approach in renal disease: from discovery to implementationJoost P Schanstra, Harald MischakBioanalysis|February 20, 2016
Implementation of CE-MS-identified proteome-based biomarker panels in drug development and patient managementAnna Stepczynska, Joost P Schanstra, Harald MischakExpert Opinion on Drug Discovery|December 15, 2017
Urinary peptidomics in kidney disease and drug researchMagdalena Krochmal, Joost P Schanstra, Harald MischakAnalytical and Bioanalytical Chemistry|August 16, 2008
Capillary electrophoresis-mass spectrometry in urinary proteome analysis: current applications and future developmentsJochen Metzger, Joost P Schanstra, Harald MischakNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 26, 2015
Body fluid peptide and protein signatures in diabetic kidney diseasesJoachim Jankowski, Joost P Schanstra, Harald MischakAdvances in Chronic Kidney Disease|November 4, 2010
Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical applicationHarald Mischak, Christian Delles, Julie Klein, et al.Proteomics|February 10, 2025
Clinical Proteomics, Quo Vadis?Harald Mischak, Joost P Schanstra, Antonia Vlahou, et al.Kidney International|February 17, 2016
The role of urinary peptidomics in kidney disease researchJulie Klein, Jean-Loup Bascands, Harald Mischak, et al.Bioanalysis|January 16, 2014
Classical MALDI-MS versus CE-based ESI-MS proteomic profiling in urine for clinical applicationsAmaya Albalat, Holger Husi, Angelique Stalmach, et al.Pageof 47